Invivoscribe’s NGS Assay for determining Somatic Hypermutation status in patients with chronic lymphocytic leukemia (CLL).
Products are for professional/laboratory use only.
The immunoglobulin heavy-chain variable region gene (IgHV) mutational status is considered the gold standard for prognosis in chronic lymphocytic leukemia (CLL)1.
